Company AB Science Deutsche Boerse AG

A8D

FR0010557264

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

EPS Revisions

Annual profits - Rate of surprise

Sector Specialty & Advanced Pharmaceuticals

Market Closed - Deutsche Boerse AG Other stock markets 02:05:34 2024-04-19 am EDT			5-day change	1st Jan Change
1.91 ^EUR	-3.73%		-13.18%	-47.38%

Apr. 04	AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada	MT
Apr. 03	AB Science: reconsideration possible for masitinib in ALS	CF

AB Science specializes in research, development, and sales of kinase protein inhibitors (KPI), therapeutic drugs used in treating cancerous tumors, inflammatory and neuro-degenerative diseases in both humans and animals.

Number of employees: 89

EUR in Million	2021	Weight	2022	Weight	Delta
Protein Kinase Inhibitors 100.0 %	2	100.0 %	1	100.0 %	-40.39%

EUR in Million	2021	Weight	2022	Weight	Delta
France 100.0 %	2	100.0 %	1	100.0 %	-40.39%

Managers	Title	Age	Since
Alain Moussy CEO	Chief Executive Officer	-	01-07-10
Laurent Guy DFI	Director of Finance/CFO	-	01-12-31
Christian Fassotte CTO	Chief Tech/Sci/R&D Officer	-	18-03-31
Alexis Bernard PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Alain Moussy CEO	Chief Executive Officer	-	01-07-10
Patrick Moussy BRD	Director/Board Member	-	01-07-10
Cécile de Guillebon BRD	Director/Board Member	62	21-06-26
Catherine Johnston-Roussillon BRD	Director/Board Member	66	21-06-26
Guillemette Latscha BRD	Director/Board Member	-	21-06-26
Renaud Sassi BRD	Director/Board Member	-	21-06-26

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	49,567,190	32,740,001 ( 66.05 %)	0	66.05 %

Name	Equities	%	Valuation
Alain Moussy 37.85 %	19,331,068	37.85 %	53 M €
Allianz Global Investors GmbH (France) 0.2553 %	130,377	0.2553 %	356 242 €
La Française Asset Management SAS 0.1527 %	78,000	0.1527 %	213 127 €
Financière Arbevel SA 0.0881 %	45,017	0.0881 %	123 004 €
Degroof Petercam Asset Services SA 0.0783 %	40,000	0.0783 %	109 296 €
Banque Degroof Petercam Luxembourg SA 0.0783 %	40,000	0.0783 %	109 296 €
FINEXIS SA 0.0509 %	26,000	0.0509 %	71 042 €
La Mondiale SAM (Investment Portfolio) 0.0308 %	15,717	0.0308 %	42 945 €
Lyxor International Asset Management SAS 0.0272 %	13,892	0.0272 %	37 959 €
Degroof Petercam Gestion 0.0196 %	10,000	0.0196 %	27 324 €

AB Science SA

3, avenue George V

75008, Paris

+33 1 47 20 00 14

http://www.ab-science.com

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.968 EUR

Average target price

6.895 EUR

Spread / Average Target

+250.36%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
KYOWA KIRIN CO. LTD.	+10.08%	9.12B
SK BIOPHARMACEUTICALS CO., LTD.	-17.63%	4.8B
YUHAN CORPORATION	+0.73%	3.8B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+16.55%	3.72B
INDIVIOR PLC	+27.76%	2.58B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-26.11%	2.36B
BETTA PHARMACEUTICALS CO., LTD.	-30.09%	2.11B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+7.15%	1.86B
VELOXIS PHARMACEUTICALS A/S	-0.50%	1.64B

Specialty & Advanced Pharmaceuticals